OBJECTIVES: This study aimed to evaluate the incidence of venous thromboembolism (VTE) cases at the Leeds General Infirmary, Leeds, UK, as well as to survey current VTE practices and preventative strategies at other UK-based electrophysiology (EP) centres. METHODS: This retrospective study involved all patients who underwent EP studies at Leeds General Infirmary from January 2014 to December 2016. In addition, a telephone survey was conducted of 35 other UK-based EP centres. RESULTS: Of 1,020 patients who underwent EP studies at Leeds General Infirmary, 0.3% developed a post-procedural VTE. In addition, 28 other EP centres were surveyed (response rate: 80%), of which 18% reported VTE cases in the last two years. There were wide variations in VTE prevention strategies and the use of post-procedural thromboprophylaxis. CONCLUSION: Despite the low incidence of VTE cases, many UK centres continue to experience this complication with no consensus on optimal preventative strategies. As current VTE guidelines do not recommend antithrombotics after EP studies, further research is needed.
OBJECTIVES: This study aimed to evaluate the incidence of venous thromboembolism (VTE) cases at the Leeds General Infirmary, Leeds, UK, as well as to survey current VTE practices and preventative strategies at other UK-based electrophysiology (EP) centres. METHODS: This retrospective study involved all patients who underwent EP studies at Leeds General Infirmary from January 2014 to December 2016. In addition, a telephone survey was conducted of 35 other UK-based EP centres. RESULTS: Of 1,020 patients who underwent EP studies at Leeds General Infirmary, 0.3% developed a post-procedural VTE. In addition, 28 other EP centres were surveyed (response rate: 80%), of which 18% reported VTE cases in the last two years. There were wide variations in VTE prevention strategies and the use of post-procedural thromboprophylaxis. CONCLUSION: Despite the low incidence of VTE cases, many UK centres continue to experience this complication with no consensus on optimal preventative strategies. As current VTE guidelines do not recommend antithrombotics after EP studies, further research is needed.
Authors: A Michelucci; E Antonucci; A A Conti; A Alessandrello Liotta; S Fedi; L Padeletti; M C Porciani; D Prisco; R Abbate; G F Gensini Journal: Am Heart J Date: 1999-07 Impact factor: 4.749
Authors: Christian Sticherling; Francisco Marin; David Birnie; Giuseppe Boriani; Hugh Calkins; Gheorghe-Andrei Dan; Michele Gulizia; Sigrun Halvorsen; Gerhard Hindricks; Karl-Heinz Kuck; Angel Moya; Tatjana Potpara; Vanessa Roldan; Roland Tilz; Gregory Y H Lip Journal: Europace Date: 2015-06-23 Impact factor: 5.214
Authors: Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori Journal: Eur Heart J Date: 2014-08-29 Impact factor: 29.983
Authors: Oussama M Wazni; Antonio Rossillo; Nassir F Marrouche; Eduardo B Saad; David O Martin; Mandeep Bhargava; Dianna Bash; Salwa Beheiry; Mark Wexman; Domenico Potenza; Ennio Pisano; Raffaele Fanelli; Aldo Bonso; Sakis Themistoclakis; Demet Erciyes; Walid I Saliba; Robert A Schweikert; Johannes Brachmann; Antonio Raviele; Andrea Natale Journal: J Cardiovasc Electrophysiol Date: 2005-06
Authors: John Fanikos; Amanda Rao; Andrew C Seger; Danielle Carter; Gregory Piazza; Samuel Z Goldhaber Journal: Am J Med Date: 2013-02 Impact factor: 4.965